Curcuma longa polyphenols improve insulin-mediated lipid accumulation and attenuate proinflammatory response of 3T3-L1 adipose cells during oxidative stress through regulation of key adipokines and antioxidant enzymes

BioFactors

Volumn 42, Issue 4, 2016, Pages 418-430

  Septembre Malaterre, Axelle ^a,b   Le Sage, Fanny ^a,b   Hatia, Sarah ^a,b   Catan, Aurélie ^a,b   Janci, Laurent ^c   Gonthier, Marie Paule ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ DE LA RÉUNION   (France)

^c Coopérative Agricole des Huiles Essentielles de Bourbon ^*  (France)

Author keywords

adipokines; adipose cells; antioxidant enzymes; Curcuma longa polyphenols; inflammation; oxidative stress

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; CATALASE; CURCUMA LONGA EXTRACT; CURCUMIN; DEMETHOXYCURCUMIN; DIDEMETHOXYCURCUMIN; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; POLYPHENOL; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

3T3 CELL LINE; ADIPOCYTE; ADIPOSE TISSUE CELL; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CURCUMA LONGA; ELECTROSPRAY MASS SPECTROMETRY; GENE EXPRESSION; LIPID STORAGE; METABOLIC DISORDER; MOUSE; NONHUMAN; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; REGULATORY MECHANISM; STRUCTURE ACTIVITY RELATION;

EID: 84982162772     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.1288     Document Type: Article

References (46)

1. Kopelman, P. G. (2000) Obesity as a medical problem. Nature 404, 635–643.
2. Zelko, I. N., Mariani, T. J., and Folz, R. J. (2002) Superoxide dismutase multigene family: A comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Rad. Biol. Med. 33, 337–349.
3. Bray, G. A. (2004) Medical consequences of obesity. J. Clin. Endocrinol. Metab. 89, 2583–2589.
4. Okuno, Y., Matsuda, M., Kobayashi, H., Morita, K., Suzuki, E., Fukuhara, A., Komuro, R., Shimabukuro, M., and Shimomura, I. (2008) Adipose expression of catalase is regulated via a novel remote PPARgamma-responsive region. Biochem. Biophys. Res. Commun. 366, 698–704.
5. Berg, A. H., Combs, T. P., and Scherer, P. E. (2002) ACRP30/adiponectin: An adipokine regulating glucose and lipid metabolism. Trends Endocrinol. Metab. 13, 84–89.
6. Havel, P. J. (2002) Control of energy homeostasis and insulin action by adipocyte hormones: Leptin, acylation stimulating protein, and adiponectin. Curr. Opin. Lipidol. 13, 51–59.
7. Ouchi, N., Kihara, S., Funahashi, T., Matsuzawa, Y., and Walsh, K. (2003) Obesity, adiponectin and vascular inflammatory disease. Curr. Opin. Lipidol. 14, 561–566.
8. Kershaw, E. E. and Flier, J. S. (2004) Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab. 89, 2548–2556.
9. Aprahamian, T. R. and Sam, F. (2011) Adiponectin in cardiovascular inflammation and obesity. Int. J. Inflamm. 2011, 1–8.
10. Ouchi, N., Parker, J. L., Lugus, J. J., and Walsh, K. (2011) Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol. 11, 85–97.
11. Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., and Nakajima, Y. (2004) Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest. 114, 1752–1761.
12. Kusminski, C. M. and Scherer, P. E. (2012) Mitochondrial dysfunction in white adipose tissue. Trends Endocrinol. Metab. 23, 435-443.
13. Rosen, E. D., Walkey, C. J., Puigserver, P., and Spiegelman, B. M. (2000) Transcriptional regulation of adipogenesis. Genes Dev. 14, 1293–1307.
14. Fernyhough, M. E., Okine, E., Hausman, G., Vierck, J. L., and Dodson, M. V. (2007) PPAR and GLUT-4 expression as developmental regulators/markers for preadipocyte differentiation into an adipocyte. Domest Anim. Endocrinol. 33, 367–378.
15. Carrière, A., Carmona, M. C., Fernandez, Y., Rigoulet, M., Wenger, R. H., Pénicaud, L., and Casteilla, L. (2004) Mitochondrial reactive oxygen species control the transcription factor CHOP-10/GADD153 and adipocyte differentiation: A mechanism for hypoxia-dependent effect. J. Biol. Chem. 279, 40462–40469.
16. Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., and Chen, H. (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112, 1821–1830.
17. Merlotti, C., Morabito, A., and Pontiroli, A. E. (2014) Prevention of type 2 diabetes; a systematic review and meta-analysis of different intervention strategies. Diabetes, Obesity Metab. 16, 719–727.
18. Scalbert, A. and Williamson, G. (2000) Dietary intake and bioavailability of polyphenols. J. Nutr. 130, 2073S–2085S.
19. Wang, S., Moustaid-Moussa, N., Chen, L., Mo, H., Shastri, A., Su, R., Bapat, P., Kwun, I., and Shen, C. L. (2012) Novel insights of dietary polyphenols and obesity. J. Nutr. Biochem. 25, 1–18.
20. Siriwardhana, N., Kalupahana, N. S., Cekanova, M., LeMieux, M., Greer, B., and Moustaid-Moussa, N. (2013) Modulation of adipose tissue inflammation by bioactive food compounds. J. Nutr. Biochem. 24, 613–623.
21. Baret, P., Septembre-Malaterre, A., Rigoulet, M., Lefebvre d'Hellencourt, C., Priault, M., Gonthier, M. P., and Devin, A. (2013) Dietary polyphenols preconditioning protects 3T3-L1 preadipocytes from mitochondrial alterations induced by oxidative stress. Int. J. Biochem. Cell Biol. 45, 167–174.
22. Hatia, S., Septembre-Malaterre, A., Le Sage, F., Badiou-Beneteau, A., Baret, P., Payet, B., Lefebvre d'Hellencourt, C., and Gonthier, M. P. (2014) Evaluation of antioxidant properties of major dietary polyphenols and their protective effect on 3T3-L1 preadipocytes and red blood cells exposed to oxidative stress. Free Rad. Res. 48, 387–401.
23. Aggarwal, B., Surh, Y.-J., Shishodia, S., Sundaram, C., Malani, N., and Ichikawa, H. (2007) in: The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. Advances in experimental medicine and biology. Back N., Cohen I.R., Kritchevsky D., Abel Lajtha N.S., Paoletti R. eds., Springer; pp 1–75.
24. Weisberg, S. P., Leibel, R., and Tortoriello, D. V. (2008) Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity. Endocrinology 149, 3549–3558.
25. Aggarwal, B. B. and Sung, B. (2009) Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol. Sci. 30, 85–94.
26. Folin, O. and Denis, W. (1915) A colorimetric estimation of phenols and phenol derivatives in urine. J. Biol. Chem. 22, 305–308.
27. Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248–254.
28. Rice-Evans, C. A., Miller, N. J., and Paganga, G. (1996) Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Rad. Biol. Med. 20, 933–956.
29. Sreejayan, M. N. R. (1994) Curcuminoids as potent inhibitors of lipid peroxidation. J. Pharmacol. Pharmacother. 46, 1013–1016.
30. Kim, J. H., Park, S. H., Nam, S. W., Kwon, H. J., Kim, B. W., Kim, W. J., and Choi, Y. H. (2011) Curcumin stimulates proliferation, stemness acting signals and migration of 3T3-L1 preadipocytes. Int. J. Mol. Med. 28, 429–435.
31. 2 induces a transient multi-phase cell cycle arrest in mouse fibroblasts through modulating cyclin D and p21Cip1 expression. J. Biol. Chem. 277, 13761–13770.
32. Das, K. C. and Das, C. K. (2002) Curcumin (diferuloylmethane), a singlet oxygen (1O2) quencher. Biochem. Biophys. Res. Commun. 295, 62–66.
33. Hotamisligil, G. S. (2003) Inflammatory pathways and insulin action. Int. J. Obesity Relat. Metab. Disord. 27 (Suppl 3), S53–S55.
34. Kuroda, M., Mimaki, Y., Nishiyama, T., Mae, T., Kishida, H., Tsukagawa, M., Takahashi, K., Kawada, T., Nakagawa, K., and Kitahara, M. (2005) Hypoglycemic effects of turmeric (Curcuma longa L. rhizomes) on genetically diabetic KK-Ay mice. Biol. Pharm. Bull. 28, 937–939.
35. Carrière, A., Fernandez, Y., Rigoulet, M., Pénicaud, L., and Casteilla, L. (2003) Inhibition of preadipocyte proliferation by mitochondrial reactive oxygen species. FEBS Lett. 550, 163–167.
36. Tiganis, T. (2011) Reactive oxygen species and insulin resistance: the good, the bad and the ugly. Trends Pharmacol. Sci. 32, 82–89.
37. Guo, H., Ling, W., Wang, Q., Liu, C., Hu, Y., and Xia, M. (2008) Cyanidin 3-glucoside protects 3T3-L1 adipocytes against H2O2- or TNF-a-induced insulin resistance by inhibiting c-Jun NH2-terminal kinase activation. Biochem. Pharmacol. 75, 1393–1401.
38. Zhao, J., Sun, X. B., Ye, F., and Tian, W. X. (2011) Suppression of fatty acid synthase, differentiation and lipid accumulation in adipocytes by curcumin. Mol. Cell. Biochem. 351, 19–28.
39. Kim, C. Y., Le, T. T., Chen, C., Cheng, J. X., and Kim, K. H. (2011) Curcumin inhibits adipocyte differentiation through modulation of mitotic clonal expansion. J. Nutr. Biochem. 22, 910–920.
40. Considine, R. V., Sinha, M. K., Heiman, M. L., Kriauciunas, A., Stephens, T. W., Nyce, M. R., Ohannesian, J. P., Marco, C. C., McKee, L. J., Bauer, T. L, and Caro, J. F. (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 334, 292–295.
41. Kamigaki, M., Sakaue, S., Tsujino, I., Ohira, H., Ikeda, D., Itoh, N., Ishimaru, S., Ohtsuka, Y., and Nishimura, M. (2006) Oxidative stress provokes atherogenic changes in adipokine gene expression in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 339, 624–632.
42. Ohara, K., Uchida, A., Nagasaka, R., Ushio, H., and Ohshima, T. (2009) The effects of hydroxycinnamic acid derivatives on adiponectin secretion. Phytomedicine 16, 130–137.
43. Dong, S. Z., Zhao, S. P., Wu, Z. H., Yang, J., Xie, X. Z., Yu, B. L., and Nie, S. (2011) Curcumin promotes cholesterol efflux from adipocytes related to PPARgamma-LXRalpha-ABCA1 passway. Mol. Cell. Biochem. 358, 281–285.
44. Nishiyama, T., Mae, T., Kishida, H., Tsukagawa, M., Mimaki, Y., Kuroda, M., Sashida, Y., Takahashi, K., Kawada, T., Nakagawa, K., and Kitahara, M. (2005) Curcuminoids and sesquiterpenoids in turmeric (Curcuma longa L.) suppress an increase in blood glucose level in type 2 diabetic KK-Ay mice. J. Agric. Food Chem. 53, 959–963.
45. Baker, R. G., Hayden, M. S., and Ghosh, S. (2011) NF-kB, inflammation, and metabolic disease. Cell Metab. 13, 11–22.
46. Wang, S. L., Li, Y., Wen, Y., Chen, Y. F., Na, L. X., Li, S. T., and Sun, C. H. (2009) Curcumin, a potential inhibitor of up-regulation of TNF-alpha and IL-6 induced by palmitate in 3T3-L1 adipocytes through NF-kappaB and JNK pathway. Biomed. Environ. Sci. 22, 32–39.